AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Pharmaceutical Companies

653.313

-17.154-2.56%

Number of Gainers:5

Number of Losers:19

Number of Flat:19

PE:- -

High:668.086

Open:663.064

Low:648.088

Close:670.467

Volume:40.56M

Turnover:346.36M

Market Cap:91.73B

Float Cap:88.35B

Loading ...

ASX Insights Lynas Rare Earths And 2 Stocks That Might Be Priced Below Their Estimated Value

Simply Wall St.

3 ASX Dividend Stocks Paying Investors While They Wait

Simply Wall St.

Inhibitor Therapeutics Announces Annual Shareholder Meeting

Why Retail Investors Are Tracking These 3 Founder Led Australian Stocks Today

Simply Wall St.

Dimerix Completes Transfer of Acute Kidney Injury Drug Candidate's US Investigational New Drug Application, Shares Up 6%

MT Newswires Live

Mesoblast Completes Dosing in Phase 3 Rexlemestrocel-L Trial for Chronic Low Back Pain

Mesoblast Achieves Major Milestone Completing Patient Treatment in Pivotal Phase 3 Trial for Chronic Low Back Pain

THOMSON REUTERS

Dimerix Ltd-Dimerix Assumes Sponsorship of US Ind for New Asset Dmx-652

THOMSON REUTERS

Oncosil Medical - FDA Grants Hde Approval for Oncosil Device for Distal Cholangiocarcinoma

THOMSON REUTERS

ASX August 2026 Stocks That May Be Trading Below Estimated Value

Simply Wall St.

3 Founder Led Australian Stocks With Stronger Management Alignment

Simply Wall St.

Starpharma Holdings Independent Non-Executive Chairman Acquires 10% More Stock

Simply Wall St.

Flight Centre Stock And Other Founder Led Picks Worth A Closer Look

Simply Wall St.

3 Australian Dividend Powerhouses Offering 3% Yields In An Uncertain Rate Outlook

Simply Wall St.

Asian Equities Traded in the US as American Depositary Receipts Rise in Friday Trading

MT Newswires Live

ASX Growth Stocks With High Insider Ownership

Simply Wall St.

Immuron CEO Lydeamore Presents at Emerging Growth Conference

Paradigm Biopharmaceuticals' Phase 3 Knee Osteoarthritis Trial to Continue Unchanged Following Safety Board Recommendation

MT Newswires Live

Clinuvel Plans Additional Preclinical Study of VLRX-L Controlled-Release Peptide Platform in Q1 2027

3 Founder Led Australian Stocks Worth A Closer Look Right Now

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/stock/BK7508/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK7508","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","market":"AU","secType":"PLATE","nameCN":"Pharmaceutical Companies","latestPrice":653.31305,"timestamp":1787291999902,"preClose":670.46686,"halted":0,"volume":40562994,"delay":0,"changeRate":-0.025585,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":-17.153809,"latestTime":"08-21 16:00:00 AEST","open":663.06445,"high":668.0863,"low":648.08826,"amount":346356360,"amplitude":0.029827,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1787529600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1787270400000,1787292000000]],"turnoverRate":0.001591,"increases":7,"decrements":19,"flats":17,"marketCap":91731621721,"floatMarketCap":88350073177.75},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","high":668.0863,"amplitude":0.029827,"preClose":670.46686,"low":648.08826,"latestPrice":653.31305,"volume":40562994,"delay":0,"open":663.06445,"prevYearClose":644.3692,"prevWeekClose":541.582,"prevMonthClose":488.077,"prevQuarterClose":464.145,"fiveDayClose":541.582,"twentyDayClose":459.552,"sixtyDayClose":415.403,"secType":"PLATE","market":"AU","turnoverRate":0.001591,"marketCap":91731621721,"floatMarketCap":88350073177.75,"timestamp":1787291999902,"nameCN":"Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK7508\",,,,undefined,":{"bkCode":"BK7508","up":5,"down":19,"flat":19},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK7508\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660489437","title":"ASX Insights Lynas Rare Earths And 2 Stocks That Might Be Priced Below Their Estimated Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2660489437","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660489437?lang=en_us&edition=fundamental","pubTime":"2026-08-18 03:04","pubTimestamp":1786993475,"startTime":"0","endTime":"0","summary":"As the S&P/ASX 200 index faces a projected dip following last week's decline, investors are keenly observing market movements amidst global economic shifts and fluctuating commodities prices. In this climate, identifying stocks that may be undervalued can present opportunities for investors seeking potential value, with companies like Lynas Rare Earths possibly offering such prospects.","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-vau/vault-minerals-shares/news/asx-insights-lynas-rare-earths-and-2-stocks-that-might-be-pr","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-vau/vault-minerals-shares/news/asx-insights-lynas-rare-earths-and-2-stocks-that-might-be-pr","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7507","XRO.AU","BK7055","BK7016","BK7062","BK7501","BK7067","LYC.AU","SETM","ARX.AU","SLC.AU","NXL.AU","BK7095","NGI.AU","BK7508","BK4585","BK4588","BK7015","MSB.AU","BK7126","SXE.AU","NWH.AU","BK7503","FDV.AU","BK7104","BK7002","PNV.AU","GMD.AU","SPHQ","VAU.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660431738","title":"3 ASX Dividend Stocks Paying Investors While They Wait","url":"https://stock-news.laohu8.com/highlight/detail?id=2660431738","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660431738?lang=en_us&edition=fundamental","pubTime":"2026-08-18 01:19","pubTimestamp":1786987170,"startTime":"0","endTime":"0","summary":"With central banks keeping policy paths in sharp focus and 10Y bond yields edging higher, income investors are being asked to work harder for dependable cash flow. That is where Dividend Powerhouses with 5%+ yields and solid coverage come into play, offering income potential while capital is deployed. These stocks are designed to pay you while you wait. This article walks through three standouts from the screener and explains what makes each one worth a closer look.\nThe three stocks below are...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/3-asx-dividend-stocks-paying-investors-while-they-wait","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/3-asx-dividend-stocks-paying-investors-while-they-wait","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DECU","SPHQ","BK7508","BK4585","BK7501","BK7135","VIG","VOTE","RGLO","BK7067","CSL.AU","BK4588","PMDE","VGFPF","CPU.AU","FEBU","BK7157","BK7033","GXDW","BK4211","QTOC","ISBC","CBA.AU","JOYT","BK7511","BK7503"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660794482","title":"Inhibitor Therapeutics Announces Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2660794482","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660794482?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:02","pubTimestamp":1786968142,"startTime":"0","endTime":"0","summary":"Inhibitor Therapeutics announces annual shareholder meetingInhibitor Therapeutics schedules a virtual annual stockholder meeting on Sept. 15, 2026, held via the internet.Items include election of six ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDLBW5kx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MYX.AU","BK4139","INTI","BK7096","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660548151","title":"Why Retail Investors Are Tracking These 3 Founder Led Australian Stocks Today","url":"https://stock-news.laohu8.com/highlight/detail?id=2660548151","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660548151?lang=en_us&edition=fundamental","pubTime":"2026-08-17 16:32","pubTimestamp":1786955560,"startTime":"0","endTime":"0","summary":"With US and European long term yields staying elevated, investors are being paid more to sit in cash and bonds. That puts extra pressure on companies to prove they are worth the risk. Founder led companies often meet that test because leaders have their own legacy on the line. This article highlights 3 stocks from the Founder Led Companies screener that explore how that commitment can matter for a portfolio.\nThe three founder led stocks below are just a starting sample, with the full screen...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/why-retail-investors-are-tracking-these-3-founder-led-austra-4","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/why-retail-investors-are-tracking-these-3-founder-led-austra-4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["GIVE.AU","IISV.AU","ZYAU.AU","VAP.AU","BK7508","ISBC","BK7067","EIGA.AU","MAQ.AU","MSB.AU","GEAR.AU","XJO.AU","BK4211","XKO.AU","BK7046","BK7042","BK7501","BK7511","VAS.AU","BK7043","XAO.AU","STW.AU","IOZ.AU","DACE.AU","OZR.AU","IMLC.AU","BBOZ.AU","BK7070","E200.AU","IIGF.AU","SLF.AU","OZF.AU","MQG.AU","QRE.AU","QFN.AU","FLT.AU","BEAR.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660243106","title":"Dimerix Completes Transfer of Acute Kidney Injury Drug Candidate's US Investigational New Drug Application, Shares Up 6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660243106","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660243106?lang=en_us&edition=fundamental","pubTime":"2026-08-17 09:43","pubTimestamp":1786930994,"startTime":"0","endTime":"0","summary":"Dimerix  said it completed the transfer of the investigational new drug application in the US for its acute kidney injury drug candidate, DMX-652, from Mission Therapeutics, according to a Monday Australian bourse filing.Dimerix plans to advance DMX-652 into a phase 2 clinical trial for acute kidney injury associated with cardiac surgery during the second half, to investigate its potential to prevent kidney injury and preserve renal function.Its shares jumped 6% in recent trading on Monday.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","BK7508","DXB.AU","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660510599","title":"Mesoblast Completes Dosing in Phase 3 Rexlemestrocel-L Trial for Chronic Low Back Pain","url":"https://stock-news.laohu8.com/highlight/detail?id=2660510599","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660510599?lang=en_us&edition=fundamental","pubTime":"2026-08-17 08:35","pubTimestamp":1786926942,"startTime":"0","endTime":"0","summary":"Mesoblast completes dosing in Phase 3 rexlemestrocel-L trial for chronic low back painMesoblast completed patient treatment in its pivotal Phase 3 trial of rexlemestrocel-L for chronic low back pain t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDLc28Z1z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","BK7067","IE00BN0W2T93.GBP","LU0314104364.USD","NDAQ","IE00BN0W2W23.USD","IE00B64PRP62.GBP","BK4585","BK4112","LU2210149790.SGD","SG9999014039.USD","IE00BN0W2V16.EUR","BCDF","SG9999014013.SGD","IE00B3QW5Z07.USD","BK7501","IE00BGHQF748.EUR","SG9999014021.USD","BK4588","MSB.AU","LU2095319765.USD","BK7508","IE00BKPKM429.USD","SG9999014005.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660105969","title":"Mesoblast Achieves Major Milestone Completing Patient Treatment in Pivotal Phase 3 Trial for Chronic Low Back Pain","url":"https://stock-news.laohu8.com/highlight/detail?id=2660105969","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660105969?lang=en_us&edition=fundamental","pubTime":"2026-08-17 08:35","pubTimestamp":1786926923,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nTUA7TVSZ8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7501","BK7067","MSB.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660875103","title":"Dimerix Ltd-Dimerix Assumes Sponsorship of US Ind for New Asset Dmx-652","url":"https://stock-news.laohu8.com/highlight/detail?id=2660875103","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660875103?lang=en_us&edition=fundamental","pubTime":"2026-08-17 06:38","pubTimestamp":1786919913,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260816:nTUE7JZ8SR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","DXB.AU","BK7067","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660820103","title":"Oncosil Medical - FDA Grants Hde Approval for Oncosil Device for Distal Cholangiocarcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2660820103","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660820103?lang=en_us&edition=fundamental","pubTime":"2026-08-17 06:36","pubTimestamp":1786919772,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260816:nFWN44C06B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7048","OSL.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660084081","title":"ASX August 2026 Stocks That May Be Trading Below Estimated Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2660084081","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660084081?lang=en_us&edition=fundamental","pubTime":"2026-08-17 03:04","pubTimestamp":1786907063,"startTime":"0","endTime":"0","summary":"As the Australian market experiences a slight downturn, with the S&P/ASX 200 recently dropping by 0.23%, investors are keenly observing global economic developments and their potential impact on local equities. In this context, identifying stocks that might be trading below their estimated value becomes crucial, as these opportunities can offer significant long-term growth potential despite current market fluctuations.","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/3041000-choice1-main-header/1585186744280","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3041000-choice1-main-header/1585186744280"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/capital-goods/asx-nwh/nrw-holdings-shares/news/asx-august-2026-stocks-that-may-be-trading-below-estimated-v","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/capital-goods/asx-nwh/nrw-holdings-shares/news/asx-august-2026-stocks-that-may-be-trading-below-estimated-v","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IOZ.AU","NXL.AU","QFN.AU","NOL.AU","XRO.AU","BK7089","OZF.AU","BK7067","BK7104","GEAR.AU","BBOZ.AU","OZR.AU","XJO.AU","BK7062","NGI.AU","ZYAU.AU","BK7508","BK7002","BK7055","BEAR.AU","IISV.AU","SLC.AU","SLF.AU","GMD.AU","BGL.AU","BK7016","E200.AU","QRE.AU","BK7015","BK7501","WTC.AU","BK7503","IIGF.AU","MSB.AU","FDV.AU","NWH.AU","STW.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659790251","title":"3 Founder Led Australian Stocks With Stronger Management Alignment","url":"https://stock-news.laohu8.com/highlight/detail?id=2659790251","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659790251?lang=en_us&edition=fundamental","pubTime":"2026-08-16 06:29","pubTimestamp":1786832978,"startTime":"0","endTime":"0","summary":"US year ahead inflation expectations have ticked higher as energy markets stay tight, which keeps pressure on interest rates and makes many investors wary of broad market exposure. Founder led companies can react quickly because the people who built the business still set the tone and often own significant stakes. This article highlights three founder led stocks from the screener that show how that mindset can matter.\nThe three founder led stocks in this article are just a starting sample...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/3-founder-led-australian-stocks-with-stronger-management-ali","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/3-founder-led-australian-stocks-with-stronger-management-ali","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IISV.AU","VAP.AU","DACE.AU","BK7043","EIGA.AU","BK7046","FLT.AU","IMLC.AU","BBOZ.AU","BK7067","BK7501","QFN.AU","E200.AU","XKO.AU","BEAR.AU","MQG.AU","QRE.AU","IOZ.AU","BK7508","OZF.AU","IIGF.AU","GEAR.AU","MAQ.AU","BK7511","XJO.AU","GIVE.AU","SLF.AU","OZR.AU","STW.AU","ZYAU.AU","MSB.AU","BK7070","VAS.AU","BK7042","XAO.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659127926","title":"Starpharma Holdings Independent Non-Executive Chairman Acquires 10% More Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2659127926","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659127926?lang=en_us&edition=fundamental","pubTime":"2026-08-15 05:42","pubTimestamp":1786743751,"startTime":"0","endTime":"0","summary":"Potential Starpharma Holdings Limited ( ASX:SPL ) shareholders may wish to note that the Independent Non-Executive...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-spl/starpharma-holdings-shares/news/starpharma-holdings-independent-non-executive-chairman-acqui","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-spl/starpharma-holdings-shares/news/starpharma-holdings-independent-non-executive-chairman-acqui","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SPL.AU","BK7501","BK7096","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659124444","title":"Flight Centre Stock And Other Founder Led Picks Worth A Closer Look","url":"https://stock-news.laohu8.com/highlight/detail?id=2659124444","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659124444?lang=en_us&edition=fundamental","pubTime":"2026-08-15 05:28","pubTimestamp":1786742934,"startTime":"0","endTime":"0","summary":"Switzerland has just posted its strongest quarterly GDP growth since 2021, with industry and services doing the heavy lifting. In a world where policy paths and inflation stories keep shifting, that kind of resilience puts extra attention on founders who stay deeply invested in their companies. This article highlights three founder led stocks from our screener that can help you focus on long term commitment over short term headlines.\nThe founder led stocks highlighted below are just a...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/flight-centre-stock-and-other-founder-led-picks-worth-a-clos","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/flight-centre-stock-and-other-founder-led-picks-worth-a-clos","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MQG.AU","BK7042","BK7511","BK7043","BK7501","BK7067","MSB.AU","BK7508","MAQ.AU","FLT.AU","BK7046","BK7070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659124711","title":"3 Australian Dividend Powerhouses Offering 3% Yields In An Uncertain Rate Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2659124711","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659124711?lang=en_us&edition=fundamental","pubTime":"2026-08-15 01:33","pubTimestamp":1786728821,"startTime":"0","endTime":"0","summary":"With global inflation still exerting pressure and central banks keeping policy options open, reliable income has fresh appeal for investors who want clarity in a foggy rate outlook. High quality dividend powerhouses, often called Dividend Aristocrats, can offer consistent cash flows when bond yields and currencies move around. This article highlights three stocks from our Dividend Powerhouses screener that deliver 3%+ yields with covered, growing payouts.\nThe stocks covered below are just a...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/3-australian-dividend-powerhouses-offering-3-yields-in-an-un","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/3-australian-dividend-powerhouses-offering-3-yields-in-an-un","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","IMLC.AU","IOZ.AU","QFN.AU","ARTY","DACE.AU","GIVE.AU","AGIX","BK7157","OZF.AU","EIGA.AU","BK7067","GEAR.AU","BBOZ.AU","OZR.AU","XJO.AU","BK7135","VTHR","AIPO","ZYAU.AU","BK7508","CBA.AU","BK7033","QTOC","VIG","XAO.AU","VAS.AU","BEAR.AU","IISV.AU","SLF.AU","STW.AU","BK7511","VAP.AU","E200.AU","XKO.AU","QRE.AU","BK7501","BK7503","CHAT","IIGF.AU","CSL.AU","CPU.AU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659546140","title":"Asian Equities Traded in the US as American Depositary Receipts Rise in Friday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2659546140","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659546140?lang=en_us&edition=fundamental","pubTime":"2026-08-14 22:47","pubTimestamp":1786718874,"startTime":"0","endTime":"0","summary":"Asian equities traded in the US as American depositary receipts were tracking modestly higher Friday morning, rising 0.32% to 3,016.75 on the S&P Asia 50 ADR Index, which is up 0.09% for the week so far.From North Asia, the gainers were led by mobile big data platform Aurora Mobile  and video display maker LG Display , which climbed 10% and 6.2% respectively. They were followed by semiconductor company Silicon Motion Technology  and diagnostic imaging centers company Concord Medical Services , which advanced 5.1% and 3.7% respectively.The decliners from North Asia were led by fintech firm LexinFintech , which fell 3.5%. It was followed by media company Phoenix New Media  and online game developer The9 , which were down 2% and 0.2% respectively.From South Asia, the gainers were led by lender HDFC Bank  and telecommunications operator Telekomunikasi Indonesia , which increased 0.8% and 0.7% respectively. They were followed by lender ICICI Bank , which was up 0.6%.The decliners from South","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0918141705.HKD","BK7502","BK4207","AIS","CAN.AU","BK4023","JG","LU0528227936.USD","LU0791590937.USD","RDY","CCM.AU","LU0918141887.USD","NCTY","LU0181495838.USD","LU1267930656.SGD","IBN","LU0630378429.USD","LU0823039010.USD","BK4085","XITK","TLK","BK4600","LPL","LU1282648689.USD","LX","LU2279701549.SGD","INFY","CAN","BK4533","SIFY","LU0831103253.SGD","LU0197229882.USD","BK4587","AFG","BK7508","LU1105468828.SGD","SG9999004220.SGD","BK4532","LU0541501648.USD","SGXZ90724238.SGD","HDB","BK4141","CCM","RDY.AU","LU1791710400.SGD","SIMO","EDOG","BK4548","FENG","LU0348744763.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659235198","title":"ASX Growth Stocks With High Insider Ownership","url":"https://stock-news.laohu8.com/highlight/detail?id=2659235198","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659235198?lang=en_us&edition=fundamental","pubTime":"2026-08-14 03:08","pubTimestamp":1786648090,"startTime":"0","endTime":"0","summary":"The Australian market is experiencing a cautious start, with the S&P/ASX 200 futures indicating a slight dip, reflecting broader global economic concerns and fluctuating commodity prices. Amidst these conditions, growth companies with high insider ownership on the ASX are attracting attention for their potential resilience and alignment of interests between management and shareholders.","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/2052000-choice2-main-header/1585186553865","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2052000-choice2-main-header/1585186553865"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-wia/wia-gold-shares/news/asx-growth-stocks-with-high-insider-ownership-12","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-wia/wia-gold-shares/news/asx-growth-stocks-with-high-insider-ownership-12","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["AV1.AU","BK7096","BK7017","CDA.AU","BK7036","FRS.AU","BK7110","BK7093","BK7095","SKS.AU","BK7508","AWJ.AU","WIA.AU","AEM.AU","TTT.AU","BK7016","BK7104","BK7084","WZR.AU","BK7023","AR1.AU","SPL.AU","BK7501","LIN.AU","PDI.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659538801","title":"Immuron CEO Lydeamore Presents at Emerging Growth Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2659538801","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659538801?lang=en_us&edition=fundamental","pubTime":"2026-08-13 18:06","pubTimestamp":1786615589,"startTime":"0","endTime":"0","summary":"Immuron CEO Lydeamore presents at Emerging Growth ConferenceImmuron CEO Steven Lydeamore will present virtually at the Emerging Growth Conference on Aug. 19, 2026.Slot scheduled for 4:25 p.m. to 4:35 ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL1G4s0n:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMC.AU","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659184174","title":"Paradigm Biopharmaceuticals' Phase 3 Knee Osteoarthritis Trial to Continue Unchanged Following Safety Board Recommendation","url":"https://stock-news.laohu8.com/highlight/detail?id=2659184174","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659184174?lang=en_us&edition=fundamental","pubTime":"2026-08-13 09:25","pubTimestamp":1786584355,"startTime":"0","endTime":"0","summary":"Paradigm Biopharmaceuticals  said an independent Data Safety Monitoring Board recommended that the company's phase 3 clinical trial of a knee osteoarthritis treatment continue without modification, according to a Thursday filing with the Australian bourse.The trial is evaluating injectable pentosan polysulfate sodium in participants with knee osteoarthritis, with the change in pain intensity at day 112 set as the primary endpoint.The safety board issued the recommendation after completing a review of about 80% of the participants who have completed dosing, the company said.The trial's interim analysis remains on track for September.Paradigm Biopharmaceuticals shares gained 1% in recent Thursday trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","BK7508","PAR.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658976515","title":"Clinuvel Plans Additional Preclinical Study of VLRX-L Controlled-Release Peptide Platform in Q1 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2658976515","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658976515?lang=en_us&edition=fundamental","pubTime":"2026-08-12 18:13","pubTimestamp":1786529595,"startTime":"0","endTime":"0","summary":"Clinuvel plans additional preclinical study of VLRX-L controlled-release peptide platform in Q1 2027Clinuvel updated on VLRX-L, a controlled-release liquid injectable peptide platform, following precl","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDLX8KKS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","CUV.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658731819","title":"3 Founder Led Australian Stocks Worth A Closer Look Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2658731819","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658731819?lang=en_us&edition=fundamental","pubTime":"2026-08-12 14:41","pubTimestamp":1786516885,"startTime":"0","endTime":"0","summary":"With oil prices feeding into higher bond yields across major markets, investors are being reminded how quickly macro shocks can ripple through portfolios. In choppier conditions, founder led companies can look appealing because leaders often hold significant stakes and stay focused on long term value creation rather than quarterly targets. This article highlights three stocks from the Founder Led Companies screener that fit that mindset and may interest long term investors.\nThe stocks covered...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/3-founder-led-australian-stocks-worth-a-closer-look-right-no","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/3-founder-led-australian-stocks-worth-a-closer-look-right-no","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["STW.AU","FLT.AU","BK7042","ZYAU.AU","BK7043","BEAR.AU","BK7067","OZR.AU","DACE.AU","EIGA.AU","IIGF.AU","BK7070","GEAR.AU","IISV.AU","VAP.AU","BK7046","GIVE.AU","BK7511","QFN.AU","BBOZ.AU","VAS.AU","QRE.AU","MAQ.AU","XAO.AU","XKO.AU","MQG.AU","XJO.AU","IOZ.AU","IMLC.AU","E200.AU","BK7501","MSB.AU","BK7508","SLF.AU","OZF.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":3,"totalSize":82,"code":"91000000","status":"200"}]}}